These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 4890476)

  • 21. Transplantation: impact of pretransplant renal insufficiency.
    Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
    Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
    Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
    Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic venous pressure gradient and transjugular liver biopsy to assess patients with kidney failure and chronic liver disease.
    García Agudo R; Aoufi Rabih S; Pérez Roldán F; Guzmán Ames F; González Carro P; Ruiz Carrillo F; Cuesta Domínguez R
    Nefrologia; 2011; 31(4):490-2. PubMed ID: 21738254
    [No Abstract]   [Full Text] [Related]  

  • 24. [The liver share in the terminal chronic renal insufficiency].
    Schimmelpfennig W; Schimmelpfennig R; Kranz D; Buder HW; Buchali K
    Dtsch Gesundheitsw; 1970 Apr; 25(16):723-6. PubMed ID: 5483716
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemodynamic influences on sodium and water excretion in simulated hepatorenal syndrome.
    Gump FE; Mashima Y
    Surg Forum; 1970; 21():101-4. PubMed ID: 5514696
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatorenal syndrome].
    Brzozowski R
    Pol Arch Med Wewn; 1972 Oct; 49(4):357-71. PubMed ID: 4571818
    [No Abstract]   [Full Text] [Related]  

  • 27. [Characteristics of renal failure in chronic liver disease].
    Banković-Talić N; Stojković D; Ostrić V; Veljović R
    Srp Arh Celok Lek; 1989; 117(9-10):605-14. PubMed ID: 18709759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of anabolic steroids in chronic renal failure. I. Short-term effects.
    Sigler MH; Issekutz B
    Arch Intern Med; 1967 Oct; 120(4):408-16. PubMed ID: 6058096
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatorenal syndrome.
    Ali AS; Baig FN
    Am Fam Physician; 1982 Jun; 25(6):127-31. PubMed ID: 7081003
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of 22 transplantations with cadaver kidneys in 20 patients].
    Ringoir S; Derom F; Schoofs E
    J Urol Nephrol (Paris); 1968 Sep; 74(9):674-81. PubMed ID: 4180585
    [No Abstract]   [Full Text] [Related]  

  • 31. Thyrotrophin response to intravenous thyrotrophin-releasing hormone in patients with hepatic and renal disease.
    Pokroy N; Epstein S; Hendricks S; Pimstone B
    Horm Metab Res; 1974 Mar; 6(2):132-6. PubMed ID: 4208128
    [No Abstract]   [Full Text] [Related]  

  • 32. Protein malnutrition and decreased protein turnover in chronic renal allograft failure.
    Baltzan MA; Shoker AS; Baltzan RB
    Clin Nephrol; 1997 Feb; 47(2):112-6. PubMed ID: 9049459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation: impact of pretransplant renal insufficiency.
    Pham PT; Wilkinson AH
    Liver Transpl; 2008 May; 14(5):592-5. PubMed ID: 18433066
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental observations on the changes in renal function and acid-base equilibrium during chronic liver diseases].
    Agnoli GC; Bernardi P; Cariani A; Montini T
    Boll Soc Ital Biol Sper; 1969 Dec; 45(23):1511-5. PubMed ID: 5401718
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of pretransplant renal function on survival after liver transplantation.
    Gonwa TA; Klintmalm GB; Levy M; Jennings LS; Goldstein RM; Husberg BS
    Transplantation; 1995 Feb; 59(3):361-5. PubMed ID: 7871566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with forty-seven renal homotransplantations from cadaveric donors with emphasis on the donor with marginally acceptable kidneys.
    Smith RB; Martin DC; Terasaki PI; Mims MM; Kaufman JJ; Goldman R; Rubini M; Goodwin WE
    Am Surg; 1969 Jan; 35(1):1-11. PubMed ID: 4885448
    [No Abstract]   [Full Text] [Related]  

  • 37. [Renal excretion of urea in chronic kidney disease and in kidney transplantation].
    Teplan V; Schück O; Nádvorníková H; Kocandrle V
    Vnitr Lek; 1979 Nov; 25(11):1079-84. PubMed ID: 390864
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined ascitic-fluid and furosemide infusion in the management of ascites.
    Eknoyan G; Martinez-Maldonado M; Yium JJ; Suki WN
    N Engl J Med; 1970 Mar; 282(13):713-7. PubMed ID: 5416204
    [No Abstract]   [Full Text] [Related]  

  • 39. Dialysis in the treatment of renal failure in patients with liver disease.
    Wilkinson SP; Weston MJ; Parsons V; Williams R
    Clin Nephrol; 1977 Jul; 8(1):287-92. PubMed ID: 884909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatorenal syndrome (a review of the literature)].
    Makovetskaia GA; Munina LN; Soshnikova MA; Kryshkovets DV
    Vopr Okhr Materin Det; 1978 Mar; 23(3):46-9. PubMed ID: 347708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.